Hypothesis

Microglial senescence transforms the brain’s intrinsic 'inefficiency-eviction' program from active pruning to passive accumulation of metabolically compromised neurons, thereby converting a potentially adaptive quality-control mechanism into a driver of age-related cognitive decline.

Mechanistic reasoning

• In young brains, neurons with low ATP production or weak synaptic activity upregulate 'eat-me' signals (e.g., phosphatidylserine exposure, complement C1q/C3 deposition) that are recognized by phagocytic microglia via TREM2 and complement receptors, leading to their removal—a process analogous to developmental pruning.
• With age, microglia themselves undergo senescence (↑p16^INK4a, SA-β-gal, SASP) that dampens phagocytic receptors and increases secretion of inflammatory cytokines, creating a milieu where 'eat-me' signals are ignored.
• Consequently, inefficient neurons persist, become stressed, and may themselves acquire senescence-like features, feeding a vicious cycle of debris accumulation and neuroinflammation.
• This mirrors the cardiac progenitor scenario where senescent CPCs accumulate due to failed clearance, suggesting a conserved tissue-level failure of immune surveillance rather than an active pruning program.

Testable predictions

1. In aged mice, cortical neurons showing reduced mitochondrial membrane potential (measured with TMRM) will exhibit higher levels of phosphatidylserine exposure but will be less frequently associated with microglia expressing phagocytic markers (CD68^high, TREM2^high) compared with young mice.
2. Senescent microglia (p16^INK4a^+ SA-β-gal^+) in aged brains will show reduced expression of complement receptors (CR3, TREM2) and elevated SASP factors (IL-6, CCL2).
3. Pharmacological clearance of senescent microglia using a senolytic (e.g., navitoclax) or genetic ablation (p16-3MR model) will increase the colocalization of inefficient neurons with phagocytic microglia and reduce their numbers, concomitant with improved performance in hippocampal-dependent memory tasks.
4. Overexpressing a phagocytic receptor (TREM2) specifically in microglia of aged mice will rescue the clearance of inefficient neurons without altering overall microglial numbers, confirming that receptor deficiency, not microglial loss, drives the phenotype.

Experimental approach

• Use Thy1-YFP mice to visualize neurons; isolate synaptosomes and measure mitochondrial potential via flow cytometry.
• Immunohistochemistry for p16, SA-β-gal, CD68, TREM2, C3, and phosphatidylserine (Annexin V) in young (3 mo) vs aged (24 mo) cortex and hippocampus.
• Treat aged cohorts with navitoclax (1 mg/kg, twice weekly for 4 weeks) or vehicle; assess neuronal density, microglial senescence markers, and behavior (Morris water maze, novel object recognition).
• In parallel, generate CX3CR1-CreER;Trem2^fl/fl mice to knock down TREM2 in microglia of aged animals and test whether blocking phagocytosis exacerbates neuron accumulation.
• Statistical analysis: two-way ANOVA with age and treatment as factors; significance set at p<0.05.

If predictions hold, the data would support the notion that aging converts an active, efficiency-based neuronal eviction program into a passive loss-of-clearance phenotype, positioning microglial senescence as a therapeutic target to preserve cognitive function.